Predictive analytics for cellular behavior

Predictive Analytics for Cellular Behavior delivers Biotoken-powered, AI-ready dynamic cellular analysis data to enable predictive biology (BioAI). By transforming live-cell behavior into structured, trajectory-based datasets, the platform allows organizations to predict biological outcomes earlier and with greater accuracy.

Designed for biotech and pharmaceutical companies, cell therapy developers, and advanced research organizations, this solution empowers teams to embed predictive AI directly into drug development, immunotherapy, and precision medicine.

Unlike traditional static endpoint measurements, TeraCyte’s approach captures continuous single-cell trajectories, creating a new data layer for cellular analysis. This enables earlier potency prediction, improved decision-making, reduced development risk, and more consistent biological performance — accelerating innovation from discovery through production.